Financhill
Sell
20

YYAI Quote, Financials, Valuation and Earnings

Last price:
$1.03
Seasonality move :
51.49%
Day range:
$0.91 - $1.06
52-week range:
$0.88 - $53.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.50x
P/B ratio:
1.88x
Volume:
145.1K
Avg. volume:
386.4K
1-year change:
-76.74%
Market cap:
$15.1M
Revenue:
$8.4M
EPS (TTM):
-$331.23
Period Ending 2020-04-30 2021-04-30 2022-04-30 2023-04-30 2024-04-30
Revenue $686.2K $10.8M $16.1M $9.9M $8.4M
Revenue Growth (YoY) -- 1474.55% 49.04% -38.38% -15.37%
 
Cost of Revenues $1.4M $7.7M $11.9M $7.1M $5M
Gross Profit -$684.7K $3.1M $4.2M $2.8M $3.4M
Gross Profit Margin -99.79% 28.91% 26.24% 28% 40.41%
 
R&D Expenses $180K $339.4K $736.1K $65.2K --
Selling, General & Admin $5.9M $6.5M $50.2M $24.7M $9.8M
Other Inc / (Exp) -$198.4K -$1.1M $10.4M $2M -$6.8M
Operating Expenses $6M $6.9M $50.9M $24.7M $9.8M
Operating Income -$6.7M -$3.7M -$46.7M -$22M -$6.4M
 
Net Interest Expenses $2.3M $13.8M $10.2M $5.3M $2.4M
EBT. Incl. Unusual Items -$9.2M -$18.6M -$46.5M -$25.3M -$15.6M
Earnings of Discontinued Ops. -- -- -$5.2M -$45.9M --
Income Tax Expense -- -- -- -- --
Net Income to Company -$9.2M -$18.6M -$51.8M -$71.2M -$15.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$9.2M -$18.6M -$51.8M -$71.2M -$15.6M
 
Basic EPS (Cont. Ops) -$2,960.00 -$5,568.00 -$10,768.00 -$5,084.58 -$648.80
Diluted EPS (Cont. Ops) -$2,960.00 -$5,568.00 -$10,768.00 -$5,084.58 -$648.80
Weighted Average Basic Share $3.1K $3.3K $4.8K $14K $24.1K
Weighted Average Diluted Share $3.1K $3.3K $4.8K $14K $24.1K
 
EBITDA -$6.9M -$4.8M -$36.2M -$8.4M -$13.1M
EBIT -$6.9M -$4.8M -$36.3M -$20M -$13.2M
 
Revenue (Reported) $686.2K $10.8M $16.1M $9.9M $8.4M
Operating Income (Reported) -$6.7M -$3.7M -$46.7M -$22M -$6.4M
Operating Income (Adjusted) -$6.9M -$4.8M -$36.3M -$20M -$13.2M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $2.6M $5.4M $2.4M $2.3M $361.5K
Revenue Growth (YoY) -- 106.12% -54.75% -6.05% -84.25%
 
Cost of Revenues $1.6M $3.3M $2.2M $1.6M $432.4K
Gross Profit $1M $2.1M $287K $647K -$70.9K
Gross Profit Margin 39.71% 38.61% 11.75% 28.18% -19.61%
 
R&D Expenses $15.4K $103.3K $15K -- --
Selling, General & Admin $1.2M $37.1M $4.8M $1.9M $1.3M
Other Inc / (Exp) -$2.1M -$864.1K -$4.2M $3.4M $4.9K
Operating Expenses $1.2M $37.2M $4.8M $1.9M $1.3M
Operating Income -$202.6K -$35.1M -$4.5M -$1.3M -$1.4M
 
Net Interest Expenses $270.7K $2.9M $427.6K $365.1K $3.2K
EBT. Incl. Unusual Items -$2.5M -$38.8M -$9.1M $1.8M -$1.4M
Earnings of Discontinued Ops. -- -- -$1.9M -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$2.5M -$38.8M -$11M $1.8M -$1.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2.5M -$38.8M -$11M $1.8M -$1.4M
 
Basic EPS (Cont. Ops) -$800.00 -$7,560.00 -$1,940.77 $38.64 -$0.24
Diluted EPS (Cont. Ops) -$800.00 -$7,560.00 -$1,940.77 $0.42 -$0.24
Weighted Average Basic Share $3.3K $5.1K $5.7K $45.6K $5.8M
Weighted Average Diluted Share $3.3K $5.1K $5.7K $4.2M $5.8M
 
EBITDA -$2.3M -$35.9M -$8.6M $2.1M -$1.4M
EBIT -$2.3M -$36M -$8.7M $2.1M -$1.4M
 
Revenue (Reported) $2.6M $5.4M $2.4M $2.3M $361.5K
Operating Income (Reported) -$202.6K -$35.1M -$4.5M -$1.3M -$1.4M
Operating Income (Adjusted) -$2.3M -$36M -$8.7M $2.1M -$1.4M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue -- $15.6M $14.2M $9.3M $4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $10.2M $11.5M $6.3M $2M
Gross Profit -$16.3K $5.3M $2.7M $3M $2.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $90K $573.2K $493.2K -- --
Selling, General & Admin $7.3M $44.4M $19.4M $20.5M $10M
Other Inc / (Exp) -$1.5M -$1.3M $11.6M $7.7M -$12M
Operating Expenses $7.4M $45M $19.9M $20.5M $10M
Operating Income -$7.4M -$39.7M -$17.2M -$17.5M -$7.9M
 
Net Interest Expenses $2.3M $16M $10.8M $3.1M $2.2M
EBT. Incl. Unusual Items -$11.4M -$57M -$16.4M -$12.9M -$22.1M
Earnings of Discontinued Ops. -- -- -$8.4M -$42M --
Income Tax Expense -- -- -- -- --
Net Income to Company -$11.4M -$57M -$24.8M -$54.9M -$22.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$11.4M -$57M -$24.8M -$54.9M -$22.1M
 
Basic EPS (Cont. Ops) -$3,600.00 -$12,872.00 -$4,090.57 -$3,113.54 -$331.23
Diluted EPS (Cont. Ops) -$3,600.00 -$12,872.00 -$4,090.57 -$3,151.76 -$331.23
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$9.1M -$40.8M -$5.6M $1.8M -$20M
EBIT -$9.1M -$40.9M -$5.7M -$9.8M -$20M
 
Revenue (Reported) -- $15.6M $14.2M $9.3M $4M
Operating Income (Reported) -$7.4M -$39.7M -$17.2M -$17.5M -$7.9M
Operating Income (Adjusted) -$9.1M -$40.9M -$5.7M -$9.8M -$20M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $3.2M $7.9M $6M $5.4M $1.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.5M $5.1M $4.7M $3.9M $865.2K
Gross Profit $668.4K $2.9M $1.3M $1.5M $201.2K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $43.6K $277.4K $34.4K -- --
Selling, General & Admin $2.3M $40.2M $8.9M $4.7M $4.8M
Other Inc / (Exp) -$1.5M -$1.7M -$492.8K $5.3M $5.1K
Operating Expenses $2.3M $40.5M $8.9M $4.7M $4.8M
Operating Income -$1.7M -$37.6M -$7.6M -$3.1M -$4.6M
 
Net Interest Expenses $750.1K $3M $3.6M $1.2M $968.9K
EBT. Incl. Unusual Items -$3.9M -$42.3M -$11.6M $915.4K -$5.6M
Earnings of Discontinued Ops. -- -- -$3.7M -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$3.9M -$42.3M -$15.3M $915.4K -$5.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$3.9M -$42.3M -$15.3M $915.4K -$5.6M
 
Basic EPS (Cont. Ops) -$1,200.00 -$8,504.00 -$2,426.57 $0.04 -$38.44
Diluted EPS (Cont. Ops) -$1,200.00 -$8,504.00 -$2,426.57 -$38.18 -$38.44
Weighted Average Basic Share $6.6K $8.8K $14.5K $67.5K $5.9M
Weighted Average Diluted Share $6.6K $8.8K $14.5K $4.2M $5.9M
 
EBITDA -$3.1M -$39.1M -$8M $2.2M -$4.6M
EBIT -$3.1M -$39.2M -$8.1M $2.1M -$4.6M
 
Revenue (Reported) $3.2M $7.9M $6M $5.4M $1.1M
Operating Income (Reported) -$1.7M -$37.6M -$7.6M -$3.1M -$4.6M
Operating Income (Adjusted) -$3.1M -$39.2M -$8.1M $2.1M -$4.6M
Period Ending 2020-04-30 2021-04-30 2022-04-30 2023-04-30 2024-04-30
Cash and Equivalents $79.9K $928.8K $665K $202.1K $229.7K
Short Term Investments -- -- -- -- $16.5M
Accounts Receivable, Net -- $762.5K $1M $399.7K $273.9K
Inventory $919.6K $3.7M $7.9M $3.2M $1.6M
Prepaid Expenses -- $140.1K $499.4K $936.9K $811K
Other Current Assets $381.5K $60.1K $272.7K $263K $197.9K
Total Current Assets $1.4M $5.6M $12.8M $5M $19.6M
 
Property Plant And Equipment -- -- $47.4K $14.8K --
Long-Term Investments -- -- -- -- --
Goodwill -- -- $6.8M -- --
Other Intangibles -- $112.9K $4.8M $101.3K $1K
Other Long-Term Assets -- -- $50.4M -- --
Total Assets $1.4M $5.7M $74.9M $7.1M $21.6M
 
Accounts Payable $1.1M $1M $5.3M $5.5M $4.7M
Accrued Expenses $396.7K $3M $5M $5.9M $4.3M
Current Portion Of Long-Term Debt $2.2M $6.1M $15M $1.5M $2.7M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $620.2K $13.8M $12.1M $10.9M $261.1K
Total Current Liabilities $4.5M $24.1M $39M $23.8M $12M
 
Long-Term Debt $1.9M $10.5K $2M $2M --
Capital Leases -- -- -- -- --
Total Liabilities $6.4M $24.1M $42.4M $25.7M $12M
 
Common Stock $24.8K $2.8K $4.2K $20 $1.8K
Other Common Equity Adj -$5K -$20.2K $55K $142.5K $183.5K
Common Equity -$5M -$18.5M $32.5M -$18.6M $9.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$5M -$18.5M $32.5M -$18.6M $9.6M
 
Total Liabilities and Equity $1.4M $5.7M $74.9M $7.1M $21.6M
Cash and Short Terms $79.9K $928.8K $665K $202.1K $16.7M
Total Debt $4.1M $6.2M $17M $3.4M $2.7M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $652.9K $1.7M $465K $285.9K $1.6M
Short Term Investments -- -- -- -- $16.5M
Accounts Receivable, Net $353.5K $846.5K $741.9K $528K $87.3K
Inventory $1.9M $8.6M $4.7M $1.7M $1.2M
Prepaid Expenses -- $475.9K $810.3K $707.6K --
Other Current Assets $271.1K $111K $1M $273K $185.5K
Total Current Assets $3.2M $13.2M $8M $3.5M $19.6M
 
Property Plant And Equipment -- -- $130.8K -- --
Long-Term Investments -- -- -- -- --
Goodwill -- $1.2M $32.6M -- --
Other Intangibles -- $2.3M $23.6M $1K $1K
Other Long-Term Assets -- -- $4.4M -- --
Total Assets $3.2M $16.7M $69M $5.5M $21.6M
 
Accounts Payable $1.3M $5.3M $5.7M $5.1M $4.6M
Accrued Expenses $455.5K $2M $7.1M $4M $6M
Current Portion Of Long-Term Debt $1.8M $2.6M -- $3.2M $2.7M
Current Portion Of Capital Lease Obligations -- -- $78K -- --
Other Current Liabilities -- $14.9M $11.4M $4.1M $304K
Total Current Liabilities $9.2M $24.9M $28.7M $18.5M $13.5M
 
Long-Term Debt $422.5K -- $2M $1.4M --
Capital Leases -- -- -- -- --
Total Liabilities $9.6M $24.9M $31.9M $19.9M $13.5M
 
Common Stock $26.6K $41.9K $13.2K $2.4K $6.4K
Other Common Equity Adj -$8K -$12.4K $226.7K $210.8K $90.6K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$6.4M -$8.2M $37.1M -$14.4M $8M
 
Total Liabilities and Equity $3.2M $16.7M $69M $5.5M $21.6M
Cash and Short Terms $652.9K $1.7M $465K $285.9K $18.1M
Total Debt $6.3M $2.6M $2.8M $4.6M $2.7M
Period Ending 2020-04-30 2021-04-30 2022-04-30 2023-04-30 2024-04-30
Net Income to Stockholders -$9.2M -$18.6M -$51.8M -$71.2M -$15.6M
Depreciation & Amoritzation $650 $2.7K $43.5K $11.6M $115.1K
Stock-Based Compensation $3.7M $71K $32.5M $746.5K --
Change in Accounts Receivable -- -$760.1K -$268.9K -$1.4M $127.5K
Change in Inventories -$919.6K -$2.8M -$4.2M $4.4M $1.6M
Cash From Operations -$4.2M -$4.5M -$12.4M -$6.4M -$3M
 
Capital Expenditures -- $30K -- -- --
Cash Acquisitions -- -- $125.7K -- --
Cash From Investing $73.4K -$30K -$1.6M -- -$16.5M
 
Dividends Paid (Ex Special Dividend) -$332.2K -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $4.6M $6.4M $18.5M $2M $3.7M
Long-Term Debt Repaid -- -$1M -$4M -$4.9M -$2.2M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$800.3K -- --
Cash From Financing $4.2M $5.4M $13.7M $5.8M $19.5M
 
Beginning Cash (CF) $2K $79.9K $916K $665K $202.1K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $82.9K $872.5K -$250.8K -$544.2K -$22.4K
Ending Cash (CF) $79.9K $928.8K $665K $202.1K $229.7K
 
Levered Free Cash Flow -$4.2M -$4.5M -$12.4M -$6.4M -$3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -$2.5M -$38.8M -$11M $1.8M -$1.4M
Depreciation & Amoritzation -- $90.8K $71.3K -- --
Stock-Based Compensation -- $32.4M $277.6K -- --
Change in Accounts Receivable -$290K -$320.2K $396.3K -$51.6K $171K
Change in Inventories -$127.3K -$3.4M $3.6M $668.7K $493.9K
Cash From Operations $50.5K -$5.9M -$1.2M -$915.3K $75.4K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$1.1M -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $500K $11.5M -$925K $1.3M --
Long-Term Debt Repaid -- -$3M -$2.1M -$20.5K -$69.5K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$790.6K -- -- --
Cash From Financing $500K $7.7M $1.9M $1.3M -$68.6K
 
Beginning Cash (CF) $104K $1M -$630.3K -$149.7K $1.7M
Foreign Exchange Rate Adjustment -$1.5K $19.7K $113.9K $95.3K -$75.1K
Additions / Reductions $550.5K $714.7K $708.3K $340.2K $6.7K
Ending Cash (CF) $652.9K $1.7M $191.9K $285.9K $1.6M
 
Levered Free Cash Flow $50.4K -$5.9M -$1.2M -$915.3K $75.4K
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -$11.4M -$57M -$24.8M -$54.9M -$22.1M
Depreciation & Amoritzation -- $134.7K -$17.1K $11.6M --
Stock-Based Compensation $3.7M $32.6M $459.7K $191.3K --
Change in Accounts Receivable -$353.5K -$490.8K $211.7K -$1.6M $101.4K
Change in Inventories -$1.9M -$6.7M $4.2M $2.4M $501.2K
Cash From Operations -$4.2M -$9M -$12.4M -$1M -$2.4M
 
Capital Expenditures -- $30K -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$1.4M -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $4.5M $16.3M $6.5M -- --
Long-Term Debt Repaid -- -$4M -$4.8M -$1.7M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $4.5M $11.5M $10.9M $1.1M $20.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $294.8K $1.1M -$1.7M $116.6K $1.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$4.2M -$9M -$12.4M -$1M -$2.4M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -$3.9M -$42.3M -$15.3M $915.4K -$5.6M
Depreciation & Amoritzation -- $132K $71.3K $115.1K --
Stock-Based Compensation -- $32.6M $555.3K -- --
Change in Accounts Receivable -$353.5K -$84.3K $396.3K $214.4K $188.3K
Change in Inventories -$993.1K -$4.9M $3.6M $1.5M $442.2K
Cash From Operations -$1.5M -$6M -$6M -$648.1K $2.7K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$1.4M -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.1M $12M -- $1.3M --
Long-Term Debt Repaid -- -$3M -$3.8M -$621.5K -$72.7K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$790.6K -- -- --
Cash From Financing $2.1M $8.2M $5.3M $654.5K $1.5M
 
Beginning Cash (CF) $183.8K $1.9M $34.7K $52.4K $1.9M
Foreign Exchange Rate Adjustment -$2.9K $8.9K $181.3K $77.3K -$135.8K
Additions / Reductions $576K $810K -$654.4K $6.4K $1.5M
Ending Cash (CF) $756.8K $2.8M -$438.5K $136.2K $3.4M
 
Levered Free Cash Flow -$1.5M -$6M -$6M -$648.1K $2.8K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock